Abstract: A motorized window treatment may provide a low-cost solution for controlling the amount of daylight entering a space through a window. The window treatment may include a covering material (e.g., a cellular shade fabric or a roller shade fabric), a drive assembly for raising and lowering the covering material, and a motor drive unit including a motor configured to drive the drive assembly to raise and lower the covering material. The motorized window treatment may comprise one or more battery packs configured to receive batteries for powering the motor drive unit. The batteries may be located out of view of a user of the motorized window treatment (e.g., in a headrail or in a battery compartment). The motorized window treatment may use various power-saving methods to lengthen the lifetime of the batteries, e.g., to reduce the motor speed to conserve additional battery power and extend the lifetime of the batteries.

Abstract: A motorized window treatment for controlling the amount of daylight entering a space through a window includes a covering material, a drive shaft, and a motor coupled to the drive shaft for raising and lowering the covering material. The window treatment also includes a spring assist unit for assisting the motor by providing a torque that equals the torque provided by the weight on the cords that lift the covering material at a position midway between fully-open and fully-closed positions to minimize motor usage and conserve battery life. The window treatment may comprise a photosensor for measuring the amount of daylight outside the window and temperature sensors for measuring the temperatures inside and outside of the window. The position of the covering material may be automatically controlled in response to the photosensor and the temperature sensors, or in response to an infrared or radio-frequency remote control.

Abstract: An improved medical implant device directed to, inter alia, (i) avoiding unwanted initial drug “burst” problems, (ii) providing a more level amount of drug delivery, (iii) reducing blood clotting, (iv) reducing the amount of drug material that remains in the implant device, and/or (v) novel materials for an implant device.

Abstract: An improved medical implant device directed to, inter alia, (i) avoiding unwanted initial drug “burst” problems, (ii) providing a more level amount of drug delivery, (iii) reducing blood clotting, (iv) reducing the amount of drug material that remains in the implant device, and/or (v) novel materials for an implant device.

Abstract: A method (and the resulting product) of making a medical implant device for releasing self-contained drugs on a controlled basis wherein the method utilizes, at least in part, computer-controlled 3-D printing equipment to deposit via nozzles portions of one or more layers of the medical implant product. The implant has an outer impervious coating, an inner matrix core, an opening and an optional bonding layer.

Abstract: An improved medical implant device directed to, inter alia, (i) avoiding unwanted initial drug “burst” problems, (ii) providing a more level amount of drug delivery, (iii) reducing blood clotting, (iv) reducing the amount of drug material that remains in the implant device, and/or (v) novel materials for an implant device.

Abstract: A multi-step method of making a mammalian subcutaneous medical implant or non-implant for releasing self-contained drugs on a controlled basis over at least a 3 day period includes depositing at least portions of one or more individual layers of the implant by at least one computer controlled 3-D printer. The 3-D printing method may be accomplished via an array of 3-D nozzles that deposit materials (such as plastics, thermoplastics, coating materials, drug-containing matrix materials, non-drug containing matrix materials, bonding materials, biodegradable materials and/or the like) in very small, precise portions. The materials may be deposited in liquid, powder, sheet or other forms. Non-implant forms may also be provided by the techniques disclosed herein.

Abstract: This application describes systems and methods for using a physical unclonable function (PUF) to authenticate a device, which may include circuitry for generating PUF values that may uniquely identify the device. According to one aspect, the device may provide enrollment PUF values to an authentication device. The device may later be authenticated if PUF values generated by the device are within a threshold distance of the enrollment PUF values. Since the PUF values are compared using a distance, it may not necessary to apply an error correcting code to the PUF values. The enrollment values and/or the calculated distance may be adjusted to compensate for time variations in the PUF values due to circuit aging. Systems and methods are also described herein for authenticating the device without revealing new PUF values to any second party, for example using a cryptographic technique known as a garbled circuit.

Abstract: An improved medical implant device directed to, inter alia, (i) avoiding unwanted initial drug “burst” problems, (ii) providing a more level amount of drug delivery, (iii) reducing blood clotting, (iv) reducing the amount of drug material that remains in the implant device, and/or (v) novel materials for an implant device.

Abstract: An improved medical implant device directed to, inter alia, (i) avoiding unwanted initial drug “burst” problems, (ii) providing a more level amount of drug delivery, (iii) reducing blood clotting, (iv) reducing the amount of drug material that remains in the implant device, and/or (v) novel materials for an implant device.

Abstract: This application describes systems and methods for using a physical unclonable function (PUF) to authenticate a device, which may include circuitry for generating PUF values that may uniquely identify the device. According to one aspect, the device may provide enrollment PUF values to an authentication device. The device may later be authenticated if PUF values generated by the device are within a threshold distance of the enrollment PUF values. Since the PUF values are compared using a distance, it may not necessary to apply an error correcting code to the PUF values. The enrollment values and/or the calculated distance may be adjusted to compensate for time variations in the PUF values due to circuit aging. Systems and methods are also described herein for authenticating the device without revealing new PUF values to any second party, for example using a cryptographic technique known as a garbled circuit.

Abstract: This application describes systems and methods for using a physical unclonable function (PUF) to authenticate a device, which may include circuitry for generating PUF values that may uniquely identify the device. According to one aspect, the device may provide enrollment PUF values to an authentication device. The device may later be authenticated if PUF values generated by the device are within a threshold distance of the enrollment PUF values. Since the PUF values are compared using a distance, it may not necessary to apply an error correcting code to the PUF values. The enrollment values and/or the calculated distance may be adjusted to compensate for time variations in the PUF values due to circuit aging. Systems and methods are also described herein for authenticating the device without revealing new PUF values to any second party, for example using a cryptographic technique known as a garbled circuit.

Abstract: This application describes systems and methods for using a physical unclonable function (PUF) to authenticate a device, which may include circuitry for generating PUF values that may uniquely identify the device. According to one aspect, the device may provide enrollment PUF values to an authentication device. The device may later be authenticated if PUF values generated by the device are within a threshold distance of the enrollment PUF values. Since the PUF values are compared using a distance, it may not necessary to apply an error correcting code to the PUF values. The enrollment values and/or the calculated distance may be adjusted to compensate for time variations in the PUF values due to circuit aging. Systems and methods are also described herein for authenticating the device without revealing new PUF values to any second party, for example using a cryptographic technique known as a garbled circuit.

Abstract: An improved medical implant device directed to, inter alia, (i) avoiding unwanted initial drug “burst” problems, (ii) providing a more level amount of drug delivery, (iii) reducing blood clotting, (iv) reducing the amount of drug material that remains in the implant device, and/or (v) novel materials for an implant device.

Abstract: A multi-step method of making a mammalian subcutaneous medical implant or non-implant for releasing self-contained drugs on a controlled basis over at least a 3 day period includes depositing at least portions of one or more individual layers of the implant by at least one computer controlled 3-D printer. The 3-D printing method may be accomplished via an array of 3-D nozzles that deposit materials (such as plastics, thermoplastics, coating materials, drug-containing matrix materials, non-drug containing matrix materials, bonding materials, biodegradable materials and/or the like) in very small, precise portions. The materials may be deposited in liquid, powder, sheet or other forms. Non-implant forms may also be provided by the techniques disclosed herein.

Abstract: An apparatus for measuring acceleration includes: a reference cavity having a first fixed reflecting surface and a second fixed reflecting surface; a sense cavity having a fixed reflecting surface and a non-fixed reflecting surface, the non-fixed reflecting surface being configured to be displaced when subject to an acceleration force; a light source to illuminate the reference and sense cavities; a controller to vary a wavelength of light emitted by the light source and/or an index of refraction of an optical medium of the cavities; a photodetector to detect light emitted by the reference and sense cavities; an interferometer sensor to measure using the detected light, for each variation of the wavelength of light and/or the index of refraction a reference displacement of the reference cavity and a sense displacement of the sense cavity; and a processor to calculate the acceleration using each of the reference displacements and the sense displacements.

Abstract: A method (and the resulting product) of making a medical implant device for releasing self-contained drugs on a controlled basis wherein the method utilizes, at least in part, computer-controlled 3-D printing equipment to deposit via nozzles portions of one or more layers of the medical implant product. The implant has an outer impervious coating, an inner matrix core, an opening and an optional bonding layer.

Abstract: A multi-step method of making a mammalian subcutaneous medical implant or non-implant for releasing self-contained drugs on a controlled basis over at least a 3 day period includes depositing at least portions of one or more individual layers of the implant by at least one computer controlled 3-D printer. The 3-D printing method may be accomplished via an array of 3-D nozzles that deposit materials (such as plastics, thermoplastics, coating materials, drug-containing matrix materials, non-drug containing matrix materials, bonding materials, biodegradable materials and/or the like) in very small, precise portions. The materials may be deposited in liquid, powder, sheet or other forms. Non-implant forms may also be provided by the techniques disclosed herein.

Abstract: A method (and the resulting product) of making a medical implant device for releasing self-contained drugs on a controlled basis wherein the method utilizes, at least in part, computer-controlled 3-D printing equipment to deposit via nozzles portions of one or more layers of the medical implant product. The implant has an outer impervious coating, an inner matrix core, an opening and an optional bonding layer.

Abstract: An improved medical implant device directed to, inter alia, (i) avoiding unwanted initial drug “burst” problems, (ii) providing a more level amount of drug delivery, (iii) reducing blood clotting, (iv) reducing the amount of drug material that remains in the implant device, and/or (v) novel materials for an implant device.